Relationship between etonogestrel level and BMI in women using the contraceptive implant for more than 1 year
Morrell, K.M.; Cremers, S.; Westhoff, C.L.; Davis, A.R.
Contraception 93(3): 263-265
2016
ISSN/ISBN: 1879-0518 PMID: 26577754 DOI: 10.1016/j.contraception.2015.11.005Document Number: 641178
Progestin-only contraceptive methods, including the 3-year, single-rod etonogestrel (ENG) implant, may be preferred for obese women to avoid additional estrogen-related thrombosis risk; however, whether obese women receive an ENG sufficient dose to suppress ovulation is understudied. Our analysis expands on the limited information currently available by studying ENG levels related to body mass index (BMI) in a community sample of primarily Hispanic women. This cross-sectional, descriptive study of 52 long-term implant users found comparable ENG levels across a wide BMI range (p=.1). These results further support that ENG levels are independent of BMI through 3 years of implant use and are thus reassuring that ENG implants will be effective for women of all BMIs.
Document emailed within 0-6 h
